<?xml version="1.0" encoding="UTF-8"?>
<p>The ELECTRON Phase II clinical study became known as ‘The Game Changer’ because it was the first ever study in which HCV therapy, without IFN, had given 100% sustained viral response for 24 weeks (SVR
 <sub>24</sub>) (
 <xref rid="table1-2040206618783924" ref-type="table">Table 1</xref>).
</p>
